ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ESLA Estrella Immunopharma Inc

1.01
0.0883 (9.58%)
22 Mar 2025 - Closed
Delayed by 15 minutes

Estrella Immunopharma Financial Summary

The current ESLA market cap is 36.54M. The company's latest EPS is USD -0.2021 and P/E is -4.90.

Year End 30 June 2024 202120222024
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -249k-1.57M-7.31M
Net Income -248k-996k-7.31M
Year End 30 June 2024 202120222024
USD (US$)USD (US$)USD (US$)
Total Assets 45.8M9.72M4.45M
Total Liabilities 1.62M2.65M181k
Total Equity -1.01M-2.26M4.27M
Year End 30 June 2024 202120222024
USD (US$)USD (US$)USD (US$)
Operating -316k-1.04M-16.07M
Investing -45.19M36.17M4.96M
Financing 45.98M-35.56M12.79M
Market Cap 36.54M
Price to Earnings Ratio -4.90
Price to Sales Ratio 0
Price to Cash Ratio 8.6
Price to Book Ratio 8.38
Dividend Yield -

Share Statistics

Shares Outstanding 36.18M
Average Volume (1 week) 61.73k
Average Volume (1 Month) 108.79k
52 Week Change -1.94%
52 Week High 3.23
52 Week Low 0.63
Spread (Intraday) 0.42 (30.64%)

Company Info

Company Name Estrella Immunopharma Inc
Address 108 w. 13th street
wilmington, delaware 19801
Website https://
Industry biological pds,ex diagnstics (2836)